Kimura Y - Search Results

1

Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats.

Tani T, Uehara K, Sudo T, Marukawa K, Yasuda Y, Kimura Y. Tani T, et al. Among authors: kimura y. Atherosclerosis. 2000 Oct;152(2):299-305. doi: 10.1016/s0021-9150(99)00480-3. Atherosclerosis. 2000. PMID: 10998457

2

Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.

Kohda N, Tani T, Nakayama S, Adachi T, Marukawa K, Ito R, Ishida K, Matsumoto Y, Kimura Y. Kohda N, et al. Among authors: kimura y. Thromb Res. 1999 Nov 15;96(4):261-8. doi: 10.1016/s0049-3848(99)00109-7. Thromb Res. 1999. PMID: 10593428

3

Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats.

Uehara K, Sugimoto K, Wada R, Yoshikawa T, Marukawa K, Yasuda Y, Kimura Y, Yagihashi S. Uehara K, et al. Among authors: kimura y. J Diabetes Complications. 1997 May-Jun;11(3):194-202. doi: 10.1016/s1056-8727(96)00023-2. J Diabetes Complications. 1997. PMID: 9174902

4

Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats.

Yamamoto Y, Yasuda Y, Kimura Y, Komiya Y. Yamamoto Y, et al. Among authors: kimura y. Eur J Pharmacol. 1998 Jul 10;352(2-3):171-8. doi: 10.1016/s0014-2999(98)00356-2. Eur J Pharmacol. 1998. PMID: 9716352

5

Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.

Sudo T, Ito H, Ozeki Y, Kimura Y. Sudo T, et al. Among authors: kimura y. Br J Pharmacol. 2001 Aug;133(8):1396-404. doi: 10.1038/sj.bjp.0704204. Br J Pharmacol. 2001. PMID: 11498527 Free PMC article.

6

Effect of probucol on triglyceride turnover in streptozotocin-diabetic rats.

Yoshino G, Matsushita M, Maeda E, Nagata K, Morita M, Matsuba K, Tani T, Horinuki R, Kimura Y, Kazumi T. Yoshino G, et al. Among authors: kimura y. Atherosclerosis. 1991 May;88(1):69-75. doi: 10.1016/0021-9150(91)90258-5. Atherosclerosis. 1991. PMID: 1878011

7

Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.

Igawa T, Tani T, Chijiwa T, Shiragiku T, Shimidzu S, Kawamura K, Kato S, Unemi F, Kimura Y. Igawa T, et al. Among authors: kimura y. Thromb Res. 1990 Feb 15;57(4):617-23. doi: 10.1016/0049-3848(90)90079-r. Thromb Res. 1990. PMID: 2158154

8

Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.

Matsumoto Y, Marukawa K, Okumura H, Adachi T, Tani T, Kimura Y. Matsumoto Y, et al. Among authors: kimura y. Thromb Res. 1999 Jul 1;95(1):19-29. doi: 10.1016/s0049-3848(98)00189-3. Thromb Res. 1999. PMID: 10403683

9

Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.

Tani T, Sakurai K, Kimura Y, Ishikawa T, Hidaka H. Tani T, et al. Among authors: kimura y. Adv Second Messenger Phosphoprotein Res. 1992;25:215-27. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1372812 No abstract available.

10

The response of serum and hepatic lipids and the aortic wall to different levels of dietary cholesterol: a comparative study between hyperlipidemia-and- atherosclerosis-prone quail and commercially available quail.

Inoue Y, Toda T, Igawa T, Tani T, Kimura Y. Inoue Y, et al. Among authors: kimura y. Tohoku J Exp Med. 1995 Jan;175(1):1-13. doi: 10.1620/tjem.175.1. Tohoku J Exp Med. 1995. PMID: 7610456 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,045 results

Search Page

Filters